Bruker (NASDAQ:BRKR) Stock Breaks Below 50 Day Moving Average - Here's What Happened

Bruker logo with Healthcare background
Image from MarketBeat Media, LLC.

Bruker Corporation (NASDAQ:BRKR - Get Free Report)'s share price crossed below its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $59.99 and traded as low as $56.13. Bruker shares last traded at $56.46, with a volume of 2,250,882 shares changing hands.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Royal Bank Of Canada began coverage on Bruker in a research note on Friday. They set a "sector perform" rating and a $66.00 price target for the company. JPMorgan Chase & Co. lowered shares of Bruker from an "overweight" rating to a "neutral" rating and set a $60.00 price target for the company. in a research note on Wednesday, October 14th. Barclays upped their price objective on shares of Bruker from $58.00 to $70.00 and gave the company an "overweight" rating in a report on Wednesday, October 7th. Zacks Research lowered Bruker from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 2nd. Finally, Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Bruker in a research note on Monday, August 31st. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $61.00.

Check Out Our Latest Stock Report on Bruker

Bruker Trading Down 9.1%

The company has a debt-to-equity ratio of 0.74, a current ratio of 1.84 and a quick ratio of 0.90. The company has a market capitalization of $8.62 billion, a P/E ratio of -51.33, a P/E/G ratio of 1.76 and a beta of 1.26. The stock's 50 day moving average is $59.99 and its 200-day moving average is $51.31.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The medical research company reported $0.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.42 by $0.14. Bruker had a positive return on equity of 13.76% and a negative net margin of 3.82%. The business had revenue of $874.00 million during the quarter, compared to the consensus estimate of $865.16 million. During the same quarter in the prior year, the company earned $0.45 earnings per share. The firm's quarterly revenue was up 1.6% compared to the same quarter last year. As a group, equities research analysts anticipate that Bruker Corporation will post 2.13 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 7th. Stockholders of record on Monday, December 21st will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, December 21st. This represents a $0.20 annualized dividend and a dividend yield of 0.4%. Bruker's dividend payout ratio is presently -18.18%.

Insiders Place Their Bets

In other Bruker news, VP Mark Munch sold 2,000 shares of the company's stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total value of $105,740.00. Following the completion of the transaction, the vice president directly owned 134,806 shares in the company, valued at $7,127,193.22. This represents a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 27.20% of the company's stock.

Hedge Funds Weigh In On Bruker

Several institutional investors have recently bought and sold shares of the business. Global Retirement Partners LLC bought a new stake in Bruker during the 2nd quarter valued at $38,000. Provenance Wealth Advisors LLC bought a new stake in shares of Bruker in the 3rd quarter valued at about $52,000. Root Financial Partners LLC purchased a new position in Bruker in the third quarter worth $57,000. Essential Partners LLC purchased a new position in Bruker during the 1st quarter worth $36,000. Finally, FNY Investment Advisers LLC purchased a new stake in shares of Bruker during the second quarter worth about $60,000. Institutional investors own 79.52% of the company's stock.

Bruker Company Profile

(Get Free Report)

Bruker develops and manufactures scientific instruments and analytical technologies used to study biological, chemical and physical materials. Its products support research and testing in areas including life sciences, pharmaceuticals, biotechnology, materials science, chemicals and clinical diagnostics. The company's offerings include nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray and microscopy instruments, and infrared and Raman spectroscopy solutions.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bruker Right Now?

Before you consider Bruker, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bruker wasn't on the list.

While Bruker currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines